iNtRON Biotechnology, Inc. (KOSDAQ:048530)
South Korea · Delayed Price · Currency is KRW 2,565.00
-430.00 (-14.36%)
Jun 10, 2026, 3:30 PM KST
iNtRON Biotechnology Market Cap
iNtRON Biotechnology has a market cap or net worth of 81.09 billion as of June 10, 2026. Its market cap has decreased by -35.88% in one year.
Market Cap
81.09B
Enterprise Value
42.67B
Revenue
5.74B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,565.00
Market Cap Chart
Since January 26, 2011, iNtRON Biotechnology's market cap has decreased from 95.30B to 81.09B, a decrease of -14.91%. That is a compound annual growth rate of -1.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 9, 2026 | 94.68B | -7.85% |
| Dec 30, 2025 | 102.75B | -44.03% |
| Dec 30, 2024 | 183.56B | -37.01% |
| Dec 28, 2023 | 291.42B | 7.98% |
| Dec 29, 2022 | 269.88B | -61.99% |
| Dec 30, 2021 | 710.00B | -22.41% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Macrogen | 124.57B |
| Vaxcell-Bio Therapeutics | 119.08B |
| MedPacto | 118.76B |
| Amicogen | 99.20B |
| GeneOne Life Science | 98.38B |
| ENCell | 90.21B |
| Prestige BioPharma | 81.61B |
| CG Invites | 69.20B |